奥妥珠单抗治疗原发性膜性肾病的有效性及安全性
Abstract
Conclusion: Obinutuzumab is an effective and safe treatment option for PMN, characterised by high clinical remission rates, a favourable safety profile, and the ability to stabilise renal function. It also demonstrates significant efficacy in refractory and RTX-resistant patients.
Fields of Study & Subjects
Renal Diseases and Glomerulopathies
Vasculitis and related conditions
Renal Transplantation Outcomes and Treatments
Publication details
- Journal / source
- Mendeley Data
- Publication date
- 4 March 2026
- Language
- EN
- Document type
- Dataset